To reflect real-world prescribing patterns, no specific medication administration protocol was mandated for inclusion given that different dosing and titration schedules are utilized for GLP-1s in real-world clinical practice
Reply I was denied bridge program, because I have MILD sleep apnea, meet all the other requirements, is there a way to appeal this decision Reply I should qualify for the Bridge program based on my BMI being 35.7
GLP-1 agonists have been used to treat type 2 diabetes for about two decades and have a long safety record
Frequently Asked Questions Can I change my injection day if my schedule changes
GLP-1 Agonists liraglutide (Saxenda) semaglutide (Wegovy) GIP/GLP-1 Agonist tirzepatide (Zepbound) In addition to helping you lose weight, GLP-1 and dual GIP/GLP-1 agonists can help lower your risk of some conditions that go hand in hand with obesity: type 2 diabetes, heart disease, heart failure, kidney disease, metabolic dysfunctionassociated steatotic liver disease, and obstructive sleep apnea